Brief: Esperion Partner Otsuka Launches Nexletol In Japan

Esperion Therapeutics

21/11/2025 13:20

Nov 21 (Reuters) - Esperion Therapeutics Inc ESPR.O:

ESPERION PARTNER OTSUKA LAUNCHES NEXLETOL® IN JAPAN FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA

ESPERION THERAPEUTICS: UNDER AGREEMENT, ESPERION WILL RECEIVE $90 MILLION IN A NEAR TERM PAYMENT AS A RESULT OF THE RECENT OTSUKA ACHIEVEMENTS

ESPERION THERAPEUTICS:  ALSO ELIGIBLE TO RECEIVE ADDITIONAL SALES MILESTONE PAYMENTS BASED ON TOTAL NET SALES ACHIEVEMENTS BY OTSUKA IN JAPAN

Source text: ID:nGNX5G7vm8

Further company coverage: ESPR.O

 ((Reuters.Briefs@thomsonreuters.com;))